Source item

Moderna, $MRNA, is now up more than 600% this year. It started 2026 at about $29, now at $225. It’s one of the best-performing stock in the S&P 500. The run: August: jumped 140% in a single day on positive late-stage melanoma vaccine data September: kept climbing toward $200 On Oct 9: up 14% after reports the NIH will push to speed up personalized cancer vaccines To see $MRNA plays and options, subscribe to Unusual Whales. You can get updates right on site. See more: https://t.co/nbPH6ZLqYs